Drug Abuse and Human Immunodeficiency virus Infection in Scotland

Acquired immune deficiency syndrome (AIDS) – United Kingdom. Communicable Diseases Scotland CDS, 1986; 86/36: 10–11

Acheson E.D. . Aids: A challenge for the public health. Lancet 1986; i: 662–5

Human immunodeficiency virus (HIV) infection. Communicable Diseases Scotland Weekly Report 1986; 86/35;15

Ludlam C.A. , Tucker J. , Steel C.M. HTLV-III infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet 1985; ii: 233–6

Peutherer J.F. , Edmond E. , Simmonds P. , Dickson J.D. , Bath G.E. . HTLV-III antibody in Edinburgh drug addicts. Lancet 1985; ii: 1129–30

Robertson J.R. , Bucknall A.B.V. , Welsby P.D. An epidemic of Aids-related virus (HTLV-III/LAV) infection amongst intravenous drug abusers in a Scottish general practice. Br Med J 1986; 292: 30

Brettle R.P. , Davidson J. , Davidson S. HTLV-III antibodies in an Edinburgh clinic. Lancet 1986; i: 1099

Centers for Disease Control. Transfusion associated HTLV-III/LAV infection from a seronegative donor – Colorado. MMWR 1986; 35: 389–91

Centers for Disease Control. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternative sites. MMWR 1986; 35: 284–7

Scottish Home and Health Department. HIV infection in Scotland. Report of the Scottish Committee on HIV infection and Intravenous Drug Misuse. SHHD, 1986

Follet E.A.I. , McIntyre A. , O'Donnell B. HTLV-III antibody in drug abusers in the West of Scotland: the Edinburgh connection. Lancet 1986; i: 446–7

Jesson W.J. , Thorp R.W. , Mortimer P.P. , Oates J.K. . Prevalence of anti-HTLV-III in UK risk groups 1984/85. Lancet 1986; i: 155

Franceschi S. , Tirelli U. , Vaccher E. Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military base. Lancet 1986; i: 804

Spira T.J. , Des Jarlais D.C. , Marmor M. Prevalence of antibody to lymphadenopathy associated virus among drug detoxification patients in New York. N Engl J Med 1984; 313: 467–8.

Levy N. , Carlson J.R. , Hinrichs S. The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl J Med 1986; 314: 446

Mortimer P.P. , Vandervelde E.M. , Jesson W.J. HTLV-III antibody in Swiss and English intravenous drug abusers. Lancet 1985; ii: 449–50

Fuchs D. , Blecha H.G. , Deinhardt F. High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol. Lancet 1985; i: 1506

Rodrigo J.M. , Serra M.A. , Aguilar E. HTLV-III antibodies in drug addicts in Spain. Lancet 1985; ii: 156–7

Feroni P. , Geroldi D. , Galli C. , Zanetti A.R. , Cargnel A. . HTLV-III antibody among Italian drug addicts. Lancet 1985; ii: 52–3

Aiuti F. , Rossi P. , Sirianni M.C. Igm and IgG antibodies to HTLV-III retrovirus in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J 1985; 291: 165

Angarano G. , Pastore G. , Monno L. Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet 1985; ii: 1302

Robertson J.R. , Bucknall A.B.V. , Wiggins P. . Regional variations in HIV antibody seropositivity in British intravenous drug users. Lancet 1986; i: 1435–6

Brettle R.P. . Epidemic of AIDS related virus infection among intravenous drug abusers. Br Med J 1986; 292: 1671

Acquired immune deficiency syndrome (AIDS) - United States. Communicable Diseases Scotland CDS, 1986; 86/36; 10–11

Redfield R.R. , Markham P.D. , Salahuddin M.S. Heterosexually acquired HTLV-III/LAV disease (AIDS related complex and AIDS). JAMA 1985; 254: 2094–6

Stewart G.J. , Tyler J.P.P. , Cunningham A.L. Transmission of HTLV-III by artificial insemination by donor. Lancet 1985; ii: 581–4

Kreiss J.K. , Kitchen L.W. , Prince H.E. Antibody to HTLV-III in Wives of haemophiliacs. Evidence for heterosexual transmission. Ann Intern Med 1985; 102: 623–6

Allain J.P. . Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France. N Engl J Med 1986; 315: 317

Burger H. , Weiser B. , Robinson W.S. Transmission of LAV/HTLV-III in sexual partners. Am J Med 1986; 81: 5–10

Centers for Disease Control. Recommendations for assisting in the prevention of perinatal transmission of HTLV-III/LAV and AIDS. MMWR 1985; 34: 721–32

Centers for Disease Control. HTLV-III/LAV antibody prevalence in US military recruit applicants. MMWR 1986; 35: 421–9

Friedland G. , Saltzman B.R. , Rogers M.F. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS related complex with oral candidiasis. N Engl J Med 1986; 314: 344–9

Christenson B. . Epidemiological aspects of transmission of Hepatitis B by HVsAg positive adopted children. Scand J Infect Dis 1986; 18: 105–9

Centers for Disease Control. Update: Evaluation of HTLV-III/LAV infection in health care personnel – United States. MMWR 1985; 34: 76–9

Centers for Disease Control. Apparent transmission of HTLV-III/LAV from a child to a mother providing health care. MMWR 1986; 35: 76–9

McGowan A. , Steedman D. , Schofield T.C. Parenteral drug misuse and the Accident and Emergency Department. Health Bull(Edinb) 1985; 42: 252–7

Scott G.B. , Fischl M.A. , Klimas N. Mothers of infants with the acquired immunodeficiency syndrome. JAMA 1985; 253: 363–6